Pfizer said Tuesday it raked in $63.6 billion in 2024, close to the top end of its guidance, and reaffirmed its sales goal ...

Regeneron Pharmaceuticals, one of the original and longest-standing biotech companies, is entering the dividends arena for ...

Astellas is reorganizing its management team, and while it doesn't involve a change at the top as Daiichi Sankyo announced ...

Merck is pausing HPV vaccine shipments to China “until at least midyear” as it grapples with lower demand for the shot. The ...

Omega Therapeutics anticipates filing for bankruptcy within the next week, the epigenomic medicines company said in a filing.

While 118 biologics are expected to lose patent protection in the US over the next decade, that $234 billion opportunity for ...

Noom lays off coaching and customer service staff after slower-than-expected growth in prescription weight loss drug program.

Thermo Fisher Scientific is cutting 300 employees across two viral vector manufacturing facilities in Massachusetts, marking ...

Fresh off a reorganization, Biogen’s research leader Jane Grogan says the biotech has to 'look outside the walls of the ...

Phar­ma­ceu­ti­cal in­dus­try groups cau­tion that Pres­i­dent Don­ald Trump’s tar­iffs on Chi­na, Mex­i­co and Cana­da will ...

FDA clears United Therapeutics and eGenesis for gene-edited pig kidney transplant studies, including the first clinical trial ...

Charles River Laboratories is permanently closing its pathology facility in Durham, NC, after determining it is no longer “a ...